Exponent, Inc. (EXPO), a global science and engineering consulting company yesterday reported their fiscal second quarter 2017 financial results. Exponent  reported second quarter profits of $13.8 million.

Exponent reported second quarter earnings of $0.51 per share. Exponent reported second quarter revenues of $87.8 million.   

Exponent, Inc. CEO’s  Comments

“Exponent’s second quarter results exceeded our prior outlook.  Our performance was driven by strength in our biomedical, construction consulting, electrical engineering, human factors and polymer science practices.   Exponent continued to benefit from a large human factors assessment project for a client in the consumer products industry,” commented Dr. Paul Johnston, Chief Executive Officer.  “Growth on a year-over-year basis for the second quarter of 2017 was aided by the unusually soft results in the year-ago period.  While we are still experiencing softness in a couple of industry sectors, we are encouraged by positive trends that we are seeing across the business.”

“Our market position in international construction disputes, consumer product recalls and product liability claims continues to generate brand awareness on an international scale. Exponent’s global presence continues to create additional opportunities for proactive engagements, specifically in design and regulatory consulting. Exponent’s first half results demonstrate the growing demand for our diverse expertise to address complex business issues and the resilience of our business model,” concluded Dr. Johnston.  Globe Newswire

EXPO Technical Analysis

EXPO opened trading yesterday at $58.35 which was down from the previous day’s trading close of $58.50. EXPO closed trading yesterday at $58.75 and spiked up after market to $65.71, equivalent to a 12% increase from the closing price. Taking a look at the daily chart we can see that we are in unchartered territory as with the spike up EXPO is now trading at all time highs.